Publicité
14.6 Références
1
Coons AH et al. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 1941; 47:200-202.
2
Nakane PK and Pierce GB Jr. Enzyme labeled antibodies: Preparations and applications for the localizations of antigens. J Histochem
Cytochem 1967; 14:929-931.
3
Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, Battifora H, and Brigati J. Special report: Quality control in
immunohistochemistry. Am J Clin Path 1989; 92:836.
4
Nadji M and Morales AR. Immunoperoxidase techniques: a practical approach to tumor diagnosis. ASCP Press, Chicago. 1986.
5
True LD ed. Atlas of Diagnostic Immunohistopathology. Lippincott, Philadelphia.1990.
6
Gall JG, Pardue ML. Formation of RNA-DNA hybrid molecules in cytological preparation. Proceedings of the National Academy of the
Sciences of the United States of America. 1969;63:378-383.
7
Shi S-R, Gu J, and Taylor CR. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Eaton Publishing,
Natick. 2000.
8
Miller RT, Swanson PE, and Wick MR. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise review with
practical considerations. Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):228-35.
9
Bancroft JD and Stevens A. Theory and Practice of Histological Techniques. 4th Edition. Churchill Livingstone, New York. 1996.
10
Wolff et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal
Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med 2007; 131:18–43.
11
Kiernan JA. Histological and Histochemical Methods: Theory and Practice. New York: Pergamon Press. 1981.
12
Sheehan DC. and Hrapchak BB. Theory and Practice of Histotechnology. St. Louis: C.V. Mosby Co. 1980.
13
Clinical Laboratory Improvement Amendments of 1988, Final Rule 57 FR 7163 February 28, 1992.
14
O'Leary TJ, Edmonds P, Floyd AD, Mesa-Tejada R, Robinowitz M, Takes PA, Taylor CR. Quality assurance for immunocytochemistry;
Proposed guideline. MM4-P. National Committee for Clinical Laboratory Standards (NCCLS). Wayne, PA. 1997;1-46.
15
Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and three
polyclonal antibodies. Progress in Surg Path 6:1-15. eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc., Philadelphia.
16
College of American Pathologists (CAP) Certification Program for Immunohistochemistry. Northfield IL. http://www.cap.org
17
Wilkinson DG. The theory and practice of in situ hybridisation. In: Wilkinson DG. (ed.) In Situ Hybridization A practical approach. 2nd
Edition. New York: Oxford University Press, 1998, pp.18-20.
18
Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Lab Med 1983; 14:767.
19
Omata M, Liew CT, Ashcavai M, and Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen: a
possible source of error in immunohistochemistry. Am J Clin Path 1980;73:626.
20
Wilkinson DG. In situ hybridization: A practical approach. 2nd Edition. Oxford University Press, Oxford. 1998.
21
Weiss LM, Chen Y. Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization
using oligonucleotide probes. The Journal of Histochemistry and Cytochemistry. 1991;39(9):1237-1242.
22
Pontius CA, Murphy KA, Novis DA and Hansen AJ. CLIA Compliance Handbook: The Essential Guide for the Clinical Laboratory. 2nd
Edition. Washington G-2 Reports, New York. 2003.
Système BOND Manuel d'utilisation BOND 7, 49.7556.510 A04
Droits d'auteur © 2023 Leica Biosystems Melbourne Pty Ltd
Chapitre 14 Utilisation des réactifs BOND
358
Publicité
